PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9549041-6 1997 An inhibitory study showed that the presence of cycloheximide (3 micrograms/mL) or actinomycin D (1 microgram/mL) blocked both the stimulatory effect of IGF-II on progesterone accumulation and the amplification of GH on IGF-II induced production (P > 0.01), suggesting GH amplification of IGF-II-induced progesterone accumulation is a process involving gene transcription and translation. Cycloheximide 48-61 insulin like growth factor 2 Homo sapiens 153-159 9378983-5 1997 IGF-I and IGF-II (but not basic fibroblast growth factor) were also able to protect cells from apoptosis induced by etoposide or cycloheximide. Cycloheximide 129-142 insulin like growth factor 2 Homo sapiens 10-16 9549041-6 1997 An inhibitory study showed that the presence of cycloheximide (3 micrograms/mL) or actinomycin D (1 microgram/mL) blocked both the stimulatory effect of IGF-II on progesterone accumulation and the amplification of GH on IGF-II induced production (P > 0.01), suggesting GH amplification of IGF-II-induced progesterone accumulation is a process involving gene transcription and translation. Cycloheximide 48-61 insulin like growth factor 2 Homo sapiens 220-226 9549041-6 1997 An inhibitory study showed that the presence of cycloheximide (3 micrograms/mL) or actinomycin D (1 microgram/mL) blocked both the stimulatory effect of IGF-II on progesterone accumulation and the amplification of GH on IGF-II induced production (P > 0.01), suggesting GH amplification of IGF-II-induced progesterone accumulation is a process involving gene transcription and translation. Cycloheximide 48-61 insulin like growth factor 2 Homo sapiens 220-226 2226300-10 1990 IGF-II-stimulated 3 beta HSD activity was completely inhibited by concurrent treatment with either actinomycin D or cycloheximide, suggesting that new mRNA and protein synthesis are required for IGF-II to exert its stimulatory effect. Cycloheximide 116-129 insulin like growth factor 2 Homo sapiens 0-6 2226300-10 1990 IGF-II-stimulated 3 beta HSD activity was completely inhibited by concurrent treatment with either actinomycin D or cycloheximide, suggesting that new mRNA and protein synthesis are required for IGF-II to exert its stimulatory effect. Cycloheximide 116-129 insulin like growth factor 2 Homo sapiens 195-201 17082775-5 2006 Inhibition of the synthesis of putative trans imprinting factors with cycloheximide led to loss of IGF2 imprinting in normal cultured fibroblasts, suggesting that normal cells produce proteins that act in trans to induce or maintain genomic imprinting. Cycloheximide 70-83 insulin like growth factor 2 Homo sapiens 99-103 1693565-4 1990 The release of IGF-II and IGF binding proteins into serum-free conditioned medium (1.7 pmol/10(6) cells.24 h and 0.8 pmol binding sites/10(6) cells.24 h for 3 days, respectively) is inhibited 80% by cycloheximide (10 micrograms/ml). Cycloheximide 199-212 insulin like growth factor 2 Homo sapiens 15-21